Vicore Pharma Holding AB
NASDAQ:VCREMedical - Pharmaceuticals
Healthcare
$9.90 -1.66%
-$0.24 today
- Market cap
- $279.65M
- Beta
- 0.15
Volume 0.00M
Average 0.26M
Price history
Vicore Pharma Holding AB SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-39.08%
Period high
$16.25
Period low
$8.66
Latest
$9.90
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 6-K | Nov 5, 2026 | Nov 5, 2026 | |
| 6-K | Nov 3, 2026 | Nov 3, 2026 | |
| 6-K | Oct 22, 2026 | Oct 22, 2026 | |
| SC 13G | Oct 13, 2026 | Oct 13, 2026 | |
| 6-K | Sep 30, 2026 | Sep 30, 2026 | |
| S-8 | Aug 21, 2026 | Aug 21, 2026 | |
| 6-K | Aug 21, 2026 | Aug 21, 2026 | |
| 6-K | Jul 6, 2026 | Jul 6, 2026 | |
| SEC STAFF ACTION | Jun 30, 2026 | Jun 30, 2026 | |
| CERT | Jun 30, 2026 | Jun 30, 2026 | |
| 20FR12B/A | Jun 9, 2026 | Jun 9, 2026 | |
| 20FR12B | May 22, 2026 | May 22, 2026 | |
| DRS | Apr 17, 2026 | Apr 17, 2026 |
Competitors
Who does Vicore Pharma Holding AB compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about VCRE's filings, answered from its disclosures.
What is the latest VCRE filing?
The latest filing shown is 6-K dated Nov 5, 2026.
How many recent filings does VCRE have?
Intrinsic Alpha currently shows 13 recent filings for VCRE.
Continue the stock analysis
Jump to another research area for this company.